drugset / Trial / NCT00403364

Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-controlled Trial

NCT00403364

Phase 2/3 Completed 300 enrolled IRCCS Azienda Ospedaliero-Universitaria di Bologna
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess if a sequential treatment regimen better eradicates H. pylori than does a triple drug regimen in adults with dyspepsia or peptic ulcer disease.

Timeline

Start
2003-07
Primary completion
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 1 g
Subject Clarithromycin Small molecule 500 mg
Subject tinidazole Small molecule 500 mg
Background Pantoprazole Other / unclassified 40 mg